Researchers & Healthcare Professionals

Myeloma- Update on Research and Treatment from the American Society of Hematology (ASH®) Annual Meeting

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: January 21, 2014
CE Credit Available Until: August 28, 2015
Location: Virtual Lecture
Target Audience: Oncology nurses and social workers involved in the treatment of myeloma
View: Program Slides
Read: Myeloma Newsletter | Transcript
Listen: Presentation | Q&A Session
Access: Virtual Lecture  

Activity Purpose

To educate oncology nurses and social workers about research and treatment for myeloma.

Educational Objectives

At the conclusion of this program, participants should be able to:

  • List current and emerging treatment options for myeloma patients
  • Describe updates on myeloma maintenance therapy
  • Discuss the role of clinical trials in the advancement of myeloma treatment
  • Describe advances in treatment side effects management
  • Identify communication touch points among patients and caregivers


Robert Z. Orlowski, MD, PhD
Florence Maude Thomas Cancer Research Professor, Director, Myeloma Section
Departments of Lymphoma/Myeloma and Experimental Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Sponsors and Supporters

This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation, Millennium: The Takeda Oncology Company and Onyx Pharmaceuticals.

This meeting is not sponsored, sanctioned by, or part of the 55th Annual Meeting of the American Society of Hematology.

last updated on Thursday, February 05, 2015